Exacerbation of metastatic disease shortly after administration of tamoxifen in ER negative advanced breast carcinoma. A case report

Tumori. 1989 Dec 31;75(6):566-9. doi: 10.1177/030089168907500610.

Abstract

In a patient with long untreated slow-growing osteoblastic bone metastases from an ER/PgR negative breast carcinoma, new metastatic sites in many lymphnodes pleura and massively in liver have been observed 4 weeks after receiving tamoxifen. Cause-effect relationship between administration of the drug and this unusually rapid spreading of the disease may be considered only as a hypothesis, as it is based wholly on clinical outcome. However, reporting of any exacerbation of breast cancer apparently induced by tamoxifen, even if only anecdotal, is advisable.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Female
  • Humans
  • Liver Neoplasms / chemically induced*
  • Liver Neoplasms / secondary
  • Lymphatic Metastasis
  • Middle Aged
  • Receptors, Estrogen / analysis*
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / secondary
  • Tamoxifen / adverse effects*

Substances

  • Receptors, Estrogen
  • Tamoxifen